Biomarkers, CDx & Precision Medicine Europe has spent twenty-one years convening the people defining the field in Europe. The 2026 edition is the most integrated yet.

Two co-located events. Four programmes. Seventeen content tracks. A regulatory line-up shaped around IVDR, the EU-specific regulatory framework reshaping biomarker and CDx development right now. A speaker roster of 110+ confirmed across senior pharma, regulatory, computational pathology, and academic leadership.

View the event here.